The Anti-adhesion Products for Surgical Procedures segmentation by application isolates five primary procedural domains that together drive the market’s revenue composition. _Abdominal surgery_, encompassing colorectal, hepatobiliary and general procedures, accounts for the largest share, roughly 35 % of total sales, because postoperative adhesions are most prevalent in the peritoneal cavity. _Gynecological surgery_ follows with an estimated 20 % share, reflecting high utilization in hysterectomy and endometriosis excision where adhesion formation impairs fertility. _Orthopedic surgery_ contributes about 15 % as joint replacement and spinal fusion patients demand barrier films to preserve mobility. _Cardiothoracic surgery_ also represents 15 % of the market, driven by adhesion‑related complications in coronary bypass and lung resections. Finally, _Neurosurgery_ and miscellaneous procedures together hold the remaining 10 % (8 % neurosurgery, 2 % others), where precision‑engineered gels mitigate scar tissue around delicate neural structures. These application‑specific pockets collectively shape the overall market size by aligning product development with procedure‑specific adhesion risk profiles. Consequently, manufacturers allocate R&D budgets proportionally, focusing on high‑volume abdominal and gynecological lines to capture the bulk of revenue.
